XML 40 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders’ Equity (Tables)
 9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
Schedule of various warrants/options issued and outstanding

 

     
Number of warrants/non-plan options Exercise Price Weighted Average Remaining Life (Yrs)
559,431  $3.32 9.15
151,000  $2.90 2.11
30,000  $3.32 2.11
148,005  $9.10 4.50
888,436    
Schedule of assumptions used

 

       
Expected volatility     109.48% - 113.32%
Expected dividends     None
Expected term (in years)     2.5 – 5.01
Risk free rate     2.83% – 3.01%
Schedule of stock option activity

 

                               
(in thousands except number of options and per options data)   Number of options       Weighted average exercise price       Weighted average remaining contractual term (in years)       Aggregate intrinsic value (1)  
Outstanding at beginning of period   —     $ —       —       —  
Granted   829,500       3.43       —       —  
Exercised   —       —       —       —  
Forfeited   —       —       —       —  
Outstanding at end of period   829,500     $ 3.43       8.51     $ —  
Exercisable at end of period   829,500     $ 3.43       8.51     $ —  

 

(1)The aggregate intrinsic value of options outstanding and options exercisable as of September 30, 2022 is $0, as all options are out of the money.
Schedule of common stock shares reserved for future issuance

      
Exercise of warrants    858,436 
Exercise of options unrelated to any Plan   30,000 
Exercise of stock options – 2021 Incentive Award Plan   829,500 
Total shares of common stock reserved for future issuances    1,717,936